Spectra Intelligence, May 2011, Pages: 67
and infertilitydrugs is estimated at US$9.4bn, and is forecast to increase by 7% in annual revenues to US$10bn by 2014.
In this report, The Global Market for HormonalContraceptives and InfertilityDrugs, 2011
Jain PharmaBiotech, Feb 2012, Pages: 281
transdermal products and applications include hormone replacement therapy, contraception, management of pain, angina pectoris, smoking cessation and neurological disorders such as Parkinson's disease
Spectra Intelligence, Sep 2007, Pages: 350
in the diverse areas of infertility, contraception, gynaecological disorders, and menopause.
The market for gynaecology is predicated on hormonaldrugs that have recently been subject to controversy based
Global Industry Analysts, Inc., Oct 2010, Pages: 507
43
Availability of HormonalContraceptives as OTC Drugs 43
C. Injectable Contraceptives 43
Depo-Provera
Business Insights, May 2011, Pages: 111
’s health market in 2010 was valued at $23.3bn, with a CAGR of 4.2% (2005–10). It is forecasted to reach $32.8bn by 2016 at a CAGR of 5.9% (2010–16).
Hormonalcontraceptives was the largest selling drug
Spectra Intelligence, Jan 2006, Pages: 580
to Treat Insomnia, 2005
Table 3.21 Drugs in Development for Restless Legs Syndrome, 2005
Table 4.1 Estimated Global Sales & Forecasts of Leading HormonalContraceptives and InfertilityDrugs, 2004
Global Industry Analysts, Inc., Oct 2006, Pages: 496
Outlook III-53
Leading Players in German InfertilityDrugs Market III-53
German Women Record Highest Usage Rate of Contraceptive Pill III-53
Condoms Market III-53
Product Introductions III-53
Strategic
Frost & Sullivan, May 1997
- Conclusions
- Introduction to the Industry
- Industry Definitions
- Industry Organizations
- Challenges in the HormonalContraceptive Industry
- Challenges in the Infertility Pharmaceutical
Arrowhead Publishers, Dec 2006, Pages: 348
12.3.1 Osteoporosis
12.3.2 Cancer
12.3.3 Menopause-Related Conditions
12.3.4 Male Sexual Dysfunctions
12.3.5 Infertility
12.3.6 Contraception
12.4 Leading Reproductive Hormones on the Market
12
GlobalData, Sep 2011, Pages: 78
therapeutics market is weak. The global market currently has hormonal therapy as the mainstay for the treatment for endometriosis. At present, the treatment options are limited to gonadotropin-releasing hormone
Fuji-Keizai USA, Inc., Feb 2005, Pages: 151
This report looks at the worldwide prescription drug market for women's health and estimates the market outlook to 2009. The research study shows that, while the global economy has had its ups
Apollo Managed Care Consultants, Feb 2011, Pages: 1225
; Experimental Drug Therapy; Chelation therapy; Diabetes management therapy/supplies; Diabetic foot ulcers - Regranex gel therapy; Gonadotropin-releasing hormone therapy; H. pylori testing and therapy; HIV Drug
